Financial toxicity refers to the financial strain and hardship that patients and their families experience due to the high costs associated with medical care, including diagnosis, treatment, medications, and related expenses. In the context of non-Hodgkin’s lymphoma (NHL), a type…
Non-Hodgkin’s lymphoma (NHL) research increasingly recognizes that addressing social determinants of health is essential to improving outcomes for patients. Social determinants of health are the conditions in which people are born, grow, live, work, and age—factors like socioeconomic status, education,…
Aging-related comorbidities can significantly complicate the care of patients with non-Hodgkin’s lymphoma (NHL), creating challenges that affect diagnosis, treatment decisions, and overall management. Non-Hodgkin’s lymphoma is a diverse group of blood cancers that primarily affect lymphocytes, a type of white…
Exercise research plays a crucial role in non-Hodgkin’s lymphoma (NHL) survivorship by providing evidence-based insights into how physical activity can improve health outcomes, enhance quality of life, and potentially reduce the risk of cancer recurrence. This research helps shape guidelines…
Nutritional research holds significant promise for improving treatment tolerance in non-Hodgkin’s lymphoma (NHL), a diverse group of blood cancers that often require intensive therapies such as chemotherapy, immunotherapy, and sometimes radiation. Treatment for NHL can be physically demanding, frequently causing…
Non-Hodgkin’s lymphoma (NHL) research addresses fatigue management through a multifaceted approach that combines understanding the causes of fatigue, developing behavioral and pharmacological interventions, and integrating supportive care strategies tailored to patients’ needs. Fatigue is one of the most common and…
Neurocognitive testing holds significant potential in predicting complications in patients with non-Hodgkin’s lymphoma (NHL), particularly neurological and cognitive impairments that may arise due to the disease itself or its treatment. NHL, a diverse group of blood cancers affecting lymphocytes, can…
Caregiver support research plays a crucial role in the care of individuals with non-Hodgkin’s lymphoma by identifying, developing, and improving resources and interventions that help caregivers manage the complex demands of supporting patients through diagnosis, treatment, and survivorship. This research…
Early detection research has the potential to significantly improve non-Hodgkin’s lymphoma (NHL) screening programs by enabling diagnosis at earlier stages, which can lead to better treatment outcomes and survival rates. NHL is a diverse group of blood cancers that originate…
Non-Hodgkin’s lymphoma (NHL) research exploring brain-body immune connections delves deeply into how the immune system interacts with the nervous system, particularly focusing on lymphomas that affect or involve the central nervous system (CNS). This research investigates the complex dialogue between…